GLP-1/GIP’s innovative mechanism, targeting both GLP-1 and GIP receptors, offers a promising avenue for advancing the understanding of metabolic diseases. Its potential effects on enhancing glycemic control and influencing appetite make it a focal point in studies aimed at tackling diabetes and obesity at a molecular level. The nasal spray format particularly enhances the scope of its application in longitudinal studies due to ease of use and the ability to administer consistent doses over time.















Reviews
There are no reviews yet.